AP&T: 会阴超声可预测溃疡性结肠炎的内镜和组织学愈合情况

2020-07-08 MedSci原创 MedSci原创

经腹超声可用于评估溃疡性结肠炎(UC)患者的炎症;然而,对直肠的评估还是有一定的缺陷,本项研究旨在评估会阴超声是否可用于预测UC直肠的内镜和组织学愈合。

背景

经腹超声可用于评估溃疡性结肠炎(UC)患者的炎症;然而,对直肠的评估还是有一定的缺陷,本项研究旨在评估会阴超声是否可用于预测UC直肠的内镜和组织学愈合。

 

方法

研究人员纳入包括53例需要结肠镜检查的UC成人,并在结肠镜检查和直肠活检之前或之后的一周内,结合会阴超声和经腹超声进行了检查。Mayo内镜评分(MES)≤1定义为内镜愈合,Geboes评分<2.1,Robats组织病理学指数≤6,Nancy指数≤1定义为组织学愈合。经会阴超声记录林伯格评分和肠壁厚度,同时研究人员还测量了粪便钙卫蛋白水平。

 

结果

结肠镜检查和经腹超声检查在直肠以外的所有节段之间均具有良好的相关性。会阴超声检查的直肠肠壁厚度和Limberg评分与直肠MES和组织学指标密切相关。肠壁厚度≤4mm可以预测内镜(曲线下面积[AUC] = 0.90)和组织学(AUC = 0.87-0.89)愈合。在多变量logistic回归分析中,仅会阴超声检查的肠壁厚度是直肠内窥镜和组织学愈合的重要独立预测因子(P<0.05),可预测性优于粪便钙卫蛋白。

 

结论

会阴超声可预测直肠的内镜和组织学愈合。经会阴超声与经腹超声的结合使整个结肠直肠可见,是治疗目标策略的理想方式。

 

原始出处:

Shintaro Sagami. Et al. Transperineal ultrasound predicts endoscopic and histological healing in ulcerative colitis.Alimentary Pharmacology and Therapeutics.2020.

 

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1695179, encodeId=a94f16951e94e, content=<a href='/topic/show?id=c76e6645438' target=_blank style='color:#2F92EE;'>#溃疡性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66454, encryptionId=c76e6645438, topicName=溃疡性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=787129789891, createdName=nymo, createdTime=Tue May 18 18:02:43 CST 2021, time=2021-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1926275, encodeId=ea1d19262e508, content=<a href='/topic/show?id=9238e767680' target=_blank style='color:#2F92EE;'>#组织学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77676, encryptionId=9238e767680, topicName=组织学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc0372, createdName=bnurmamat, createdTime=Thu Jul 23 05:02:43 CST 2020, time=2020-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1262195, encodeId=c7c112621956b, content=<a href='/topic/show?id=0ceb30545e0' target=_blank style='color:#2F92EE;'>#内镜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30545, encryptionId=0ceb30545e0, topicName=内镜)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c30265, createdName=jiafufeng@yaho, createdTime=Fri Jul 10 00:02:43 CST 2020, time=2020-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1513687, encodeId=6e31151368eb0, content=<a href='/topic/show?id=1a4825835c5' target=_blank style='color:#2F92EE;'>#会阴#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25835, encryptionId=1a4825835c5, topicName=会阴)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=769010584396, createdName=ms5439512287675881, createdTime=Fri Jul 10 00:02:43 CST 2020, time=2020-07-10, status=1, ipAttribution=)]
    2021-05-18 nymo
  2. [GetPortalCommentsPageByObjectIdResponse(id=1695179, encodeId=a94f16951e94e, content=<a href='/topic/show?id=c76e6645438' target=_blank style='color:#2F92EE;'>#溃疡性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66454, encryptionId=c76e6645438, topicName=溃疡性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=787129789891, createdName=nymo, createdTime=Tue May 18 18:02:43 CST 2021, time=2021-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1926275, encodeId=ea1d19262e508, content=<a href='/topic/show?id=9238e767680' target=_blank style='color:#2F92EE;'>#组织学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77676, encryptionId=9238e767680, topicName=组织学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc0372, createdName=bnurmamat, createdTime=Thu Jul 23 05:02:43 CST 2020, time=2020-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1262195, encodeId=c7c112621956b, content=<a href='/topic/show?id=0ceb30545e0' target=_blank style='color:#2F92EE;'>#内镜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30545, encryptionId=0ceb30545e0, topicName=内镜)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c30265, createdName=jiafufeng@yaho, createdTime=Fri Jul 10 00:02:43 CST 2020, time=2020-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1513687, encodeId=6e31151368eb0, content=<a href='/topic/show?id=1a4825835c5' target=_blank style='color:#2F92EE;'>#会阴#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25835, encryptionId=1a4825835c5, topicName=会阴)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=769010584396, createdName=ms5439512287675881, createdTime=Fri Jul 10 00:02:43 CST 2020, time=2020-07-10, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1695179, encodeId=a94f16951e94e, content=<a href='/topic/show?id=c76e6645438' target=_blank style='color:#2F92EE;'>#溃疡性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66454, encryptionId=c76e6645438, topicName=溃疡性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=787129789891, createdName=nymo, createdTime=Tue May 18 18:02:43 CST 2021, time=2021-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1926275, encodeId=ea1d19262e508, content=<a href='/topic/show?id=9238e767680' target=_blank style='color:#2F92EE;'>#组织学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77676, encryptionId=9238e767680, topicName=组织学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc0372, createdName=bnurmamat, createdTime=Thu Jul 23 05:02:43 CST 2020, time=2020-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1262195, encodeId=c7c112621956b, content=<a href='/topic/show?id=0ceb30545e0' target=_blank style='color:#2F92EE;'>#内镜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30545, encryptionId=0ceb30545e0, topicName=内镜)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c30265, createdName=jiafufeng@yaho, createdTime=Fri Jul 10 00:02:43 CST 2020, time=2020-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1513687, encodeId=6e31151368eb0, content=<a href='/topic/show?id=1a4825835c5' target=_blank style='color:#2F92EE;'>#会阴#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25835, encryptionId=1a4825835c5, topicName=会阴)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=769010584396, createdName=ms5439512287675881, createdTime=Fri Jul 10 00:02:43 CST 2020, time=2020-07-10, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1695179, encodeId=a94f16951e94e, content=<a href='/topic/show?id=c76e6645438' target=_blank style='color:#2F92EE;'>#溃疡性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66454, encryptionId=c76e6645438, topicName=溃疡性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=787129789891, createdName=nymo, createdTime=Tue May 18 18:02:43 CST 2021, time=2021-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1926275, encodeId=ea1d19262e508, content=<a href='/topic/show?id=9238e767680' target=_blank style='color:#2F92EE;'>#组织学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77676, encryptionId=9238e767680, topicName=组织学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc0372, createdName=bnurmamat, createdTime=Thu Jul 23 05:02:43 CST 2020, time=2020-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1262195, encodeId=c7c112621956b, content=<a href='/topic/show?id=0ceb30545e0' target=_blank style='color:#2F92EE;'>#内镜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30545, encryptionId=0ceb30545e0, topicName=内镜)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c30265, createdName=jiafufeng@yaho, createdTime=Fri Jul 10 00:02:43 CST 2020, time=2020-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1513687, encodeId=6e31151368eb0, content=<a href='/topic/show?id=1a4825835c5' target=_blank style='color:#2F92EE;'>#会阴#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25835, encryptionId=1a4825835c5, topicName=会阴)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=769010584396, createdName=ms5439512287675881, createdTime=Fri Jul 10 00:02:43 CST 2020, time=2020-07-10, status=1, ipAttribution=)]

相关资讯

AP&T:溃疡性结肠炎诱导和维持治疗期间戈利木单抗血清浓度的治疗阈值分析

研究人员观察到在溃疡性结肠炎(UC)的诱导和维持治疗期间,血清戈利木单抗浓度与良好结局之间存在显着关联。但是,有关最佳治疗性血清戈利木单抗浓度阈值的数据有限。

Gastroenterology:Upadacitinib治疗中重度活动性溃疡性结肠炎II期临床效果显著

8周的Upadacitinib治疗可有效诱导中重度活动性溃疡性结肠炎患者获得病情缓解

IBD:与肠易激综合症相比,缓解期溃疡性结肠炎结肠上皮通透性明显增高

肠屏障功能障碍是溃疡性结肠炎(UC)和肠易激综合症(IBS)的致病因素,但尚不清楚与屏障功能障碍有关的因素在多大程度上是两种疾病特异性的。

盘点:溃疡性结肠炎2020年上半年重要研究进展汇总

【1】维多珠单抗和英夫利昔单抗在治疗溃疡性结肠炎中的疗效

英国NICE首次批准靶向IL-12/IL-23的单抗Stelara,用于治疗溃疡性结肠炎

英国大约有146000人患有溃疡性结肠炎,该疾病目前尚无法治愈。

JCC: 中性HGF-MET信号转导加剧了溃疡性结肠炎的肠道炎症

溃疡性结肠炎(UC)与中性粒细胞浸润过多造成的附带组织损伤有关,但这种联系尚不完全清楚。由于c-MET受体酪氨酸激酶(MET)是嗜中性粒细胞趋化和响应其配体肝细胞生长因子(HGF)的细胞毒性所必需的,